Literature DB >> 8746805

Alteration of transglutaminase activity in rat and human spinal cord after neuronal degeneration.

K Fujita1, M Ando, M Yamauchi, Y Nagata, M Honda.   

Abstract

We measured the activity of transglutaminase (TG), a Ca(2+)-dependent enzyme and a biochemical marker of cell degeneration, in the adult rat spinal cord after unilateral occlusion of a branch of the dorsal spinal artery, and compared it to the enzyme activity in the tissue on the contralateral side without ischemic damage. The affected half of the spinal cord showed a significant rise in intrinsic (endogenous) TG activity one day after ischemic insult while no apparent morphological changes were observed in the tissue. However, the enzymic activity on the affected side gradually decreased to reach the level in the non-affected tissue, accompanying severe degeneration of neuronal cells at 7 days after the surgery, then it declined to nearly half the level in the intact tissue 30 days after the operation. We also determined the TG activity in transverse sections of the human spinal cord obtained at autopsy from 5 amyotrophic lateral sclerosis (ALS) and 9 non-ALS patients. TG activity in thoracic and lumbar cords was markedly low in ALS patients not only in ventral and lateral regions but also in the dorsal portion. These findings imply that the reduced TG activity in the ALS spinal cord is one of the characteristic features of the disease reflecting exhaustion of the enzyme in the tissue resulting from degeneration of the spinal neurons through cross-linkage of soluble intraneuronal cytoplasmic proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8746805     DOI: 10.1007/bf00995383

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  A filter paper assay for transamidating enzymes using radioactive amine substrates.

Authors:  L Lorand; L K Campbell-Wilkes; L Cooperstein
Journal:  Anal Biochem       Date:  1972-12       Impact factor: 3.365

Review 2.  Transglutaminases.

Authors:  J E Folk
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

Review 3.  Searching for the function of tissue transglutaminase: its possible involvement in the biochemical pathway of programmed cell death.

Authors:  L Fesus; V Thomazy
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

4.  Induction and activation of tissue transglutaminase during programmed cell death.

Authors:  L Fesus; V Thomazy; A Falus
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

5.  Stimulation of transglutaminase activity by GM1-ganglioside and alpha-sialylcholesterol in superior cervical and nodose ganglia excised from adult rat.

Authors:  M Ando; Y Nakashima; Y Nagata
Journal:  J Neurochem       Date:  1991-12       Impact factor: 5.372

6.  Localization and activity of transglutaminase, a retinoid-inducible protein, in developing rat spinal cord.

Authors:  M J Perry; L W Haynes
Journal:  Int J Dev Neurosci       Date:  1993-06       Impact factor: 2.457

7.  Selective alterations in transglutaminase activity of rat superior cervical ganglia in response to neurotransmitters, high potassium and sialic acid-containing compounds.

Authors:  M Ando; S Kunii; T Tatematsu; Y Nagata
Journal:  Brain Res       Date:  1993-02-26       Impact factor: 3.252

8.  Human factor XIII: fibrin-stabilizing factor.

Authors:  L Lorand; M S Losowsky; K J Miloszewski
Journal:  Prog Hemost Thromb       Date:  1980

9.  Rapid and transient alterations in transglutaminase activity in rat superior cervical ganglia following denervation or axotomy.

Authors:  M Ando; S Kunii; T Tatematsu; Y Nagata
Journal:  Neurosci Res       Date:  1993-06       Impact factor: 3.304

10.  Regional distribution of cholinergic neurons in human spinal cord transections in the patients with and without motor neuron disease.

Authors:  Y Nagata; M Okuya; R Watanabe; M Honda
Journal:  Brain Res       Date:  1982-07-29       Impact factor: 3.252

View more
  8 in total

1.  Protective effect against 17beta-estradiol on neuronal apoptosis in hippocampus tissue following transient ischemia/recirculation in mongolian gerbils via down-regulation of tissue transglutaminase activity.

Authors:  K Fujita; T Kato; K Shibayama; H Imada; M Yamauchi; N Yoshimoto; E Miyachi; Y Nagata
Journal:  Neurochem Res       Date:  2006-07-28       Impact factor: 3.996

Review 2.  Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block.

Authors:  Manuela Basso; Rajiv R Ratan
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-10       Impact factor: 6.200

3.  Alteration of enzymatic activities implicating neuronal degeneration in the spinal cord of the motor neuron degeneration mouse during postnatal development.

Authors:  K Fujita; K Shibayama; M Yamauchi; T Kato; M Ando; H Takahashi; K Iritani; N Yoshimoto; Y Nagata
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

4.  Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis.

Authors:  K Fujita; T Kato; M Yamauchi; M Ando; M Honda; Y Nagata
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

5.  The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.

Authors:  Qingmin Ruan; Janusz Tucholski; Soner Gundemir; Gail V W Johnson Voll
Journal:  Int J Clin Exp Med       Date:  2008-06-30

Review 6.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

7.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  Pathogenesis of axonal dystrophy and demyelination in alphaA-crystallin-expressing transgenic mice.

Authors:  A F Van Rijk; M A M Sweers; G F M Merkx; M Lammens; H Bloemendal
Journal:  Int J Exp Pathol       Date:  2003-04       Impact factor: 1.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.